上海市医学会妇科肿瘤学专科分会第四届委员会卵巢癌学组组员
上海市研究型医院学会妇产科转化医学研究与发展专业委员会第一届委员会委员
上海市医学会第十二届子宫内膜异位症学组组员
上海市抗癌协会肿瘤药物临床研究专业委员会委员
上海市抗癌协会青年肿瘤科学家沙龙学员
全国老年学会妇科分会青年委员
上海市浦东新区医学会妇科分会委员
Member of the Ovarian Cancer Group of the 4th Committee of the Gynecologic Oncology Branch of Shanghai Medical Association
Member of the first committee of the Translational Medicine Research and Development Committee of Obstetrics and Gynecology of Shanghai Research Hospital Association
Member of the 12th Endometriosis Group of Shanghai Medical Association
Member of the Tumor Drug Clinical Research Committee of Shanghai Anti-Cancer Association
Trainee of the Young Oncology Scientist Salon of Shanghai Anti-Cancer Association
Youth member of the Gynecology Branch of the National Gerontological Society
Member of the Gynecology Branch of Shanghai Pudong New Area Medical Association
近三年获得省部级以上奖励情况
第十八届上海市医学科技奖 青年奖 第十完成人
上海市浦东职工科技创新成果入围奖 创新成果入围奖 第一完成人
上海市抗癌协会青年肿瘤科学家沙龙学员
近三年主持课题情况
中央高校基本科研业务费专项资金资助 基于TSPO靶向的 Fe（III) -卟啉-顺铂（IV）纳米平台增强铁死亡克服卵巢癌耐药的机制研究和联合治疗策略观察 项目编号：22120240343研究年限：2024.4.1-2026.3.31
近三年参与课题情况
上海市课题 构建MnO2 NS 适配体高效检测宫颈HPV16/18L1的研究 课题编号：20204Y0141 研究年限2021.01.01-2023.12.31（已结题）
近三年发表代表性论文专著的情况
Qiang S, Hu X, Li R, Wu W, Fang K, Li H, Sun Y, Liang S, Zhao W, Wang M, Lin Y, Shi S, Dong C. CuS Nanoparticles-Loaded and Cisplatin Prodrug Conjugated Fe(III)-MOFs for MRI-Guided Combination of Chemotherapy and NIR-II Photothermal Therapy. ACS Appl Mater Interfaces. 2022 Aug 17;14(32):36503-36514.（IF=10.383）
Qiang S, Fu F, Wang J, Dong C. Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making. Front Genet. 2022 Oct 13;13:1007108.（IF=3.789）
Hu X, Li H, Li R, Qiang S, Chen M, Shi S, Dong C. A Phase-Change Mediated Intelligent Nanoplatform for Chemo/Photothermal/Photodynamic Therapy of Cancer. Adv Healthc Mater. 2023 Feb;12(5):e2202245.（IF=10）
Zhao W, Hu X, Li W, Li R, Chen J, Zhou L, Qiang S, Wu W, Shi S, Dong C. M2-Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy. Small. 2021 Apr;17(13):e2007051. （IF=13）
Awards received in the past three years
18th Shanghai Medical Science and Technology Award Youth Award The 10th recipient
Shanghai Pudong Employee Science and Technology Innovation Achievement Nomination Award Innovation Achievement Nomination Award First Completed Person
Trainee of the Shanghai Anti Cancer Association Young Oncologist Salon
Leading research projects in the past three years
Fundamental Research Funds for the Central Universities Mechanism study and combination therapy strategy observation of Fe (III) - porphyrin cisplatin (IV) nanoplatform based on TSPO targeting to enhance ferroptosis and overcome drug resistance in ovarian cancer Project Number 22120240343 Research Duration: April 1, 2024 to March 31, 2026
Participation in research projects in the past three years
Shanghai research project Study on the construction of MnO2 NS adapter for efficient detection of cervical HPV16/18L1 project number 20204Y0141 Research Duration: January 1, 2021 to December 31, 2023 (completed)
Representative papers and monographs published in the past three years
Qiang S, Hu X, Li R, Wu W, Fang K, Li H, Sun Y, Liang S, Zhao W, Wang M, Lin Y, Shi S, Dong C. CuS Nanoparticles-Loaded and Cisplatin Prodrug Conjugated Fe(III)-MOFs for MRI-Guided Combination of Chemotherapy and NIR-II Photothermal Therapy. ACS Appl Mater Interfaces. 2022 Aug 17;14(32):36503-36514.（IF=10.383）
Qiang S, Fu F, Wang J, Dong C. Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making. Front Genet. 2022 Oct 13;13:1007108.（IF=3.789）
Hu X, Li H, Li R, Qiang S, Chen M, Shi S, Dong C. A Phase-Change Mediated Intelligent Nanoplatform for Chemo/Photothermal/Photodynamic Therapy of Cancer. Adv Healthc Mater. 2023 Feb;12(5):e2202245.（IF=10）
Zhao W, Hu X, Li W, Li R, Chen J, Zhou L, Qiang S, Wu W, Shi S, Dong C. M2-Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy. Small. 2021 Apr;17(13):e2007051. （IF=13）
